LT - The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders
EN - The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07J 7/00 |
|
|
|
A61K 31/568 |
|
|
|
A61K 31/5685 |
|
|
|
A61K 31/57 |
|
|
|
A61P 25/00 |
|
|
|
A61P 25/10 |
|
|
|
A61P 25/28 |
|
|
|
C07J 1/00 |
|
|
|
C07J 41/00 |
|
European patent
| (11) |
Number of the document |
2711371 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13198584.8 |
|
Date of filing the European patent application |
2007-11-20 |
| (97) |
Date of publication of the European application |
2014-03-26 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-01-10
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
860658 P |
2006-11-21
|
US |
Inventors
| (72) |
Bäckström, Torbjörn, SE
Ragagnin, Gianna, SE
|
Grantee
| (73) |
Asarina Pharma AB,
Karolinska Institutet Science Park Fogdevreten 2, 171 65 Solna,
SE
|
Title
| (54) |
The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |
| |
The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |
